SyMapCath I™ catheter and SYMPIONEER S1™ Stimulator/Generator

DEVICE3 trials

Sponsors

SyMap Medical (Suzhou), Ltd., The Second Hospital of Nanjing Medical University

Conditions

HemodialysisHypertensionReduce Antihypertensive Drug BurdenResistant HypertensionUncontrolled Hypertension

Unknown Phase

Sympathetic Mapping/ Ablation of Renal Nerves Trial

Active, not recruitingNCT02761811

SyMap Medical (Suzhou), Ltd.Hypertension

Start: 2016-06-30End: 2026-12-31Updated: 2023-08-02

Sympathetic Mapping/ Ablation of Renal Nerves Trial - Hemodialysis

The Second Hospital of Nanjing Medical UniversityHemodialysis, Hypertension

Start: 2021-05-01End: 2023-12-31Target: 30Updated: 2021-05-04

SMART Study in Real World

Not yet recruitingNCT06780696

SyMap Medical (Suzhou), Ltd.Hypertension, Reduce Antihypertensive Drug Burden, Resistant Hypertension +1

Start: 2025-02-28End: 2029-04-30Target: 1000Updated: 2025-02-17

Related Papers

Efficacy and safety of sympathetic mapping and ablation of renal nerves for the treatment of hypertension (SMART): 6-month follow-up of a randomised, controlled trial.

2024-05-0718 citations

Rationale and Design of Sympathetic Mapping/Ablation of Renal Nerves Trial (SMART) for the Treatment of Hypertension: a Prospective, Multicenter, Single-Blind, Randomized and Sham Procedure-Controlled Study.

2022-08-308 citations